These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10502037)

  • 41. Tau imaging with [
    Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
    Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.
    Bancher C; Lassmann H; Budka H; Grundke-Iqbal I; Iqbal K; Wiche G; Seitelberger F; Wisniewski HM
    Acta Neuropathol; 1987; 74(1):39-46. PubMed ID: 2444063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.
    Komori T; Arai N; Oda M; Nakayama H; Mori H; Yagishita S; Takahashi T; Amano N; Murayama S; Murakami S; Shibata N; Kobayashi M; Sasaki S; Iwata M
    Acta Neuropathol; 1998 Oct; 96(4):401-8. PubMed ID: 9797005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia.
    Kida E; Barcikowska M; Niemczewska M
    Acta Neuropathol; 1992; 83(3):328-32. PubMed ID: 1557959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.
    Stutzbach LD; Xie SX; Naj AC; Albin R; Gilman S; ; Lee VM; Trojanowski JQ; Devlin B; Schellenberg GD
    Acta Neuropathol Commun; 2013 Jul; 1():31. PubMed ID: 24252572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy.
    Takahashi M; Weidenheim KM; Dickson DW; Ksiezak-Reding H
    J Neuropathol Exp Neurol; 2002 Jan; 61(1):33-45. PubMed ID: 11829342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein.
    Fergusson J; Landon M; Lowe J; Ward L; van Leeuwen FW; Mayer RJ
    Neurosci Lett; 2000 Jan; 279(2):69-72. PubMed ID: 10674623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
    Tsuboi Y; Josephs KA; Cookson N; Dickson DW
    Neurology; 2003 Jan; 60(2):240-5. PubMed ID: 12552038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progressive supranuclear palsy with dementia: cortical pathology.
    Bigio EH; Brown DF; White CL
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):359-64. PubMed ID: 10218631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spatial patterns of the tau pathology in progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Neurol Sci; 2013 Mar; 34(3):337-44. PubMed ID: 22411688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap.
    Urasaki K; Kuriki K; Namerikawa M; Satoh S; Ikeguchi K; Fukayama M; Saito K; Nakano I
    Neuropathology; 2000 Sep; 20(3):233-8. PubMed ID: 11132941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical study of A2B5-positive ganglioside in postmortem human brain tissue of Alzheimer disease, amyotrophic lateral sclerosis, progressive supranuclear palsy and control cases.
    Tooyama I; Yamada T; Kim SU; McGeer PL
    Neurosci Lett; 1992 Feb; 136(1):91-4. PubMed ID: 1321969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case.
    Mochizuki A; Ueda Y; Komatsuzaki Y; Tsuchiya K; Arai T; Shoji S
    Acta Neuropathol; 2003 Jun; 105(6):610-4. PubMed ID: 12669238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coexistence of PSP and MSA: a case report and review of the literature.
    Uchikado H; DelleDonne A; Uitti R; Dickson DW
    Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease.
    Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ
    Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement.
    Vermersch P; Robitaille Y; Bernier L; Wattez A; Gauvreau D; Delacourte A
    Acta Neuropathol; 1994; 87(6):572-7. PubMed ID: 8091949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.